Document:

ex10-11.htm

Exhibit 10.11

 

CHANGE OF CONTROL AGREEMENT

 

THIS AGREEMENT is entered into as of the ____ day of __________, 2010 (the "Effective Date") by and between Capitol Federal Financial, Inc. ("CFF"), a Maryland corporation, and __________ (the "Executive").

 

WITNESSETH:

 

WHEREAS, CFF owns 100% of the outstanding stock of Capitol Federal Savings Bank (the "Bank"), a federally chartered savings bank;

 

WHEREAS, Executive is the _____________ of CFF and the Bank, and as such is a key executive officer whose continued dedication, availability, advice and counsel to CFF and the Bank is deemed important to the Boards of Directors of CFF and the Bank and to the stockholders of CFF;

 

WHEREAS, CFF wishes to retain the services of Executive free from any distractions or conflicts that could arise as a result of a change in control of CFF or the Bank.

 

NOW, THEREFORE, to assure CFF of Executive's continued dedication, the availability of his advice and counsel to the Board of Directors of CFF free of any distractions resulting from a change of control, and for other good and valuable consideration, the receipt and adequacy whereof each party hereby acknowledges, CFF and Executive hereby agree as follows:

 

1.           TERM OF AGREEMENT: This Agreement shall remain in effect until cancelled by either party hereto, upon not less than 24 months prior written notice to the other party.

 

2.           CHANGE IN CONTROL: If the Executive's employment by the Bank or CFF shall be terminated by the Bank or CFF, or any successor thereto, other than for Cause or as a result of the Executive's death, disability or retirement, or terminated by the Executive for Good Reason, all as defined in Appendix A attached hereto ("Appendix A"), in either case within six (6) months preceding or twenty-four (24) months following a Change in Control of CFF or the Bank, then CFF shall:

 

(a)          Pay to the Executive in cash upon the later of the date of such Change of Control or the effective date of the Executive's termination with CFF or the Bank, an amount equal to 299% of the Employee's "base amount" as determined under Section 280G of the Internal Revenue Code of 1986, as amended (the "Code").

 

(b)          For purposes of this Agreement, a Change of Control of CFF occurs in any of the following events: (i) the acquisition by any "person" or "group" (as defined in Sections 13(d) and 14(d) of the Securities Exchange Act of 1934 ("Exchange Act")), other than CFF, any subsidiary of CFF or their employee benefit plans, directly or indirectly, as "beneficial owner" (as defined in Rule 13d-3, under the Exchange Act) of securities of CFF representing ten percent (10%) or more of either the then outstanding shares or the combined voting power of the then outstanding securities of CFF; (ii) either a majority of the directors of CFF elected at CFF's annual stockholders’ meeting shall have been nominated for election other than by or at the direction of the "incumbent directors" of CFF, or the "incumbent directors" shall cease to constitute a majority of the directors of CFF. The term "incumbent director" shall mean any director who was a director of CFF on the Effective Date and any individual who becomes a director of CFF subsequent to the Effective Date and who is elected or nominated by or at the direction of at least two-thirds of the then incumbent directors; (iii) the stockholders of CFF approve (x) a merger, consolidation or other business combination of CFF with any other "person" or "group" (as defined in Sections 13(d) and 14(d) of the Exchange Act) or affiliate thereof, other than a merger or consolidation that would result in the outstanding common stock of CFF immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into common stock of the surviving entity or a parent or affiliate thereof) at least fifty percent (50%) of the outstanding common stock of CFF or such surviving entity or a parent or affiliate thereof outstanding immediately after such merger, consolidation or other business combination, or (y) a plan of complete liquidation of CFF or an agreement for the sale or disposition by CFF of all or substantially all of CFF's assets; or (iv) any other event or circumstance which is not covered by the foregoing subsections but which the Board of Directors of CFF determines to affect control of CFF and with respect to which the Board of Directors adopts a resolution that the event or circumstance constitutes a Change of Control for purposes of the Agreement.

 

  

  

  

 

The Change of Control Date is the date on which an event described in (i), (ii), (iii) or (iv) occurs.

 

3.           LIMITATION OF BENEFITS: It is the intention of the parties that no payment be made or benefit provided to the Executive that would constitute an "excess parachute payment" within the meaning of Section 280G of the Code and any regulations thereunder, thereby resulting in a loss of an income tax deduction by CFF or the imposition of an excise tax on the Executive under Section 4999 of the Code. If the independent accountants serving as auditors for CFF immediately prior to the date of a Change of Control determine that some or all of the payments or benefits scheduled under this Agreement, when combined with any other payments or benefits provided to the Executive on a Change of Control, would constitute nondeductible excess parachute payments by CFF or any affiliate under Section 280G of the Code, then the payments or benefits scheduled under this Agreement will be reduced to one dollar less than the maximum amount which may be paid or provided without causing any such payments or benefits scheduled under this Agreement or otherwise provided on a Change of Control to be nondeductible. The determination made as to the reduction of benefits or payments required hereunder by the independent accountants shall be binding on the parties. The Executive shall have the right to designate within a reasonable period which payments or benefits will be reduced; provided, however, that if no direction is received from the Executive, CFF shall implement the reductions by reducing or eliminating payments required under this Agreement.

 

4.           LITIGATION - OBLIGATIONS - SUCCESSORS:

 

(a)          If litigation shall be brought or arbitration commenced to challenge, enforce or interpret any provision of this Agreement, and such litigation or arbitration does not end with judgment in favor of CFF, CFF hereby agrees to indemnify the Executive for his reasonable attorney's fees and disbursements incurred in such litigation or arbitration.

 

(b)          CFF's obligation to pay the Executive the compensation contemplated herein and to make the arrangements provided herein shall be absolute and unconditional and shall not be affected by any circumstances, including, without limitation, any set-off, counterclaim, recoupment, defense or other right which CFF may have against him or anyone else. All amounts payable by CFF hereunder shall be paid without notice or demand. The Executive shall not be required to mitigate the amount of any payment provided for in this Agreement by seeking other employment or otherwise.

 

(c)          CFF will require any successor (whether direct or indirect, by purchase, merger, consolidation or otherwise) to all or substantially all of the business and/or assets of CFF, by agreement in form and substance satisfactory to the Executive, to expressly assume and agree to perform this Agreement in its entirety. Failure of CFF to obtain such agreement prior to the effectiveness of any such succession shall be a breach of this Agreement and shall entitle the Executive to the compensation described in Section 2. As used in this Agreement, "CFF" shall mean Capitol Federal Financial, Inc. and any successor to its business and/or assets as aforesaid which executes and delivers the agreement provided for in this Section 4 or which otherwise becomes bound by all the terms and provisions of this Agreement by operation of law.

 

  

2

  

 

5.           NOTICES: For the purposes of this Agreement, notices and all other communications provided for in the Agreement shall be in writing and shall be deemed to have been duly given when delivered or mailed by United States registered or certified mail, return receipt requested, postage prepaid, addressed as follows:

 

	 	If to the Executive:	 
	 	 	 
	 	 	_______________________
	 	 	[Home Address or any other address] 
	 	
 

	
 

	 	 	 
	 	

If to CFF:

	Capitol Federal Financial, Inc.
	 	 	700 South Kansas Ave.
	 	 	

Topeka, Kansas 66603

or at such other address as any party may have furnished to the other in writing in accordance herewith, except that notices of change of address shall be effective only upon receipt.

 

6.           MODIFICATION - WAIVERS - APPLICABLE LAW: No provisions of this Agreement may be modified, waived or discharged unless such waiver, modification or discharge is agreed to in writing, signed by the Executive and on behalf of CFF by such officer as may be specifically designated by the Board of Directors of CFF. No waiver by either party hereto at any time of any breach by the other party hereto of, or in compliance with, any condition or provision of this Agreement to be performed by such other party shall be deemed a waiver of similar or dissimilar provisions or conditions at the same or at any prior or subsequent time. No agreements or representations, oral or otherwise, express or implied, with respect to the subject matter hereof have been made by either party which are not set forth expressly in this Agreement. The validity, interpretation, construction and performance of this Agreement shall be governed by the laws of the State of Kansas.

 

7.           INVALIDITY - ENFORCEABILITY: The invalidity or unenforceability of any provisions of this Agreement shall not affect the validity or enforceability of any other provision of this Agreement, which shall remain in full force and effect. Any provision in this Agreement which is prohibited or unenforceable in any jurisdiction shall, as to such jurisdiction, be ineffective only to the extent of such prohibition or unenforceability without invalidating or affecting the remaining provisions of this Agreement, and any such prohibition or unenforceability in any jurisdiction shall not invalidate or render unenforceable such provision in any other jurisdiction.

 

8.           SUCCESSOR RIGHTS: This Agreement shall inure to the benefit of and be enforceable by the Executive's personal or legal representatives, executors, administrators, successors, heirs, distributees, devisees and legatees. If the Executive should die while any amounts would still be payable to him hereunder, all such amounts, unless otherwise provided herein, shall be paid in accordance with the terms of this Agreement to his executor or, if there is no such executor, to his estate.

 

  

3

  

 

9.           HEADINGS: Descriptive headings contained in this Agreement are for convenience only and shall not control or affect the meaning or construction of any provision in this Agreement.

 

10.         ARBITRATION: Any dispute, controversy or claim arising under or in connection with this Agreement shall be settled exclusively by arbitration in Topeka, Kansas (or as close thereto as feasible) in accordance with the Commercial Arbitration Rules of the American Arbitration Association then in effect. CFF shall pay all administrative fees associated with such arbitration. Judgment may be entered on the arbitrator's award in any court having jurisdiction.

 

11.         CONFIDENTIALITY:

 

(a)          The Executive acknowledges that CFF may disclose certain confidential information to the Executive during the term of this Agreement to enable him to perform his duties hereunder. The Executive hereby covenants and agrees that he will not, without the prior written consent of CFF, during the term of this Agreement or at any time thereafter, disclose or permit to be disclosed to any third party by any method whatsoever any of the confidential information of CFF, nor shall Executive use such confidential information to the detriment of CFF, the Bank or their successors. For purposes of this Agreement, "confidential information" shall include, but not be limited to, any and all records, notes, memoranda, data, ideas, processes, methods, techniques, systems, formulas, patents, models, devices, programs, computer software, writings, research, personnel information, customer information, CFF' s financial information, plans, or any other information of whatever nature in the possession or control of CFF which has not been published or disclosed to the general public, or which gives to CFF an opportunity to obtain an advantage over competitors who do not know of or use it. The Executive further agrees that if his employment hereunder is terminated for any reason, he will leave with CFF and will not take originals or copies of any records, papers, programs, computer software and documents and all matter of whatever nature which bears secret or confidential information of CFF.

 

(b)          The foregoing paragraph shall not be applicable if and to the extent the Executive is required to testify in a judicial or regulatory proceeding pursuant to an order of a judge or administrative law judge issued after the Executive and his legal counsel urge that the aforementioned confidentiality be preserved.

 

(c)          The foregoing covenants will not prohibit the Executive from disclosing confidential or other information to other employees of CFF or any third parties to the extent that such disclosure is necessary to the performance of his duties under this Agreement.

 

12.         COMPLIANCE WITH SECTION 409A OF THE CODE: Notwithstanding anything herein to the contrary, any payments to be made in accordance with this Agreement shall not be made prior to the date that is 185 calendar days from the date of termination of employment of the Executive if it is determined by CFF in good faith that such payments are subject to the limitations set forth at Section 409A of the Code and regulations promulgated thereunder, and payments made in advance of such date would result in the requirement that Executive pay additional interest and taxes in accordance with Section 409A(a)(1)(B) of the Code.

 

  

4

  

 

IN WITNESS WHEREOF, the parties have executed this Agreement as of the Effective Date referred to above.

 

	  	  	 	EXECUTIVE	  
	  	  	 	  	  	  
	  	  	 	  	  	  
	  	  	 	  	  	  
	
ATTEST:

	  	 	  	  	  
	  	  	 	  	  	  
	  	  	 	  	  	  
	  	  	 	  	  	  
	  	  	 	CAPITOL FEDERAL FINANCIAL, INC	  
	  	  	 	  	  	  
	  	  	 	  	  	  
	  	  	 	  	  	  
	
ATTEST:

	  	 	
By:

	  	  

 

  

5

  

 

APPENDIX A TO CHANGE OF CONTROL AGREEMENT

Definitions:

"Cause" shall mean personal dishonesty, willful misconduct, breach of fiduciary duty involving personal profit, intentional failure to perform stated duties, willful violation of any law, rule, or regulation (other than traffic violations or similar offenses) or final cease-and-desist order, or material breach of any provision of the Change of Control Agreement.

 

"Good Reason" shall mean:

 

(i)           The assignment of duties to the Executive by CFF or the Bank or any successor thereto which (A) are materially different from the Executive's duties on the date hereof, or (B) result in the Executive having significantly less authority and/or responsibility than he has on the date hereof, without his express written consent;

 

(ii)          The removal of the Executive from or any failure to re-elect him to the position of ____________, except in connection with a termination of his employment by CFF for Cause or by reason of the Executive's disability;

 

(iii)         A reduction by CFF or the Bank of the Executive's then current base salary;

 

(iv)         The failure of CFF or the Bank to provide the Executive with substantially the same fringe benefits (including paid vacations) that were provided to him immediately prior to the date hereof; or

 

(v)          The failure of CFF to obtain the assumption of and agreement to perform this Agreement by any successor as contemplated in Section 4(c) of the Change of Control Agreement.Management Rights Deed of Agreement

 Exhibit 4.100 

MANAGEMENT RIGHTS DEED OF AGREEMENT 

THIS MANAGEMENT RIGHTS DEED OF AGREEMENT (this “Deed”) is made as of October 16, 2009 by and among: 

 

	(1)	AMARIN CORPORATION PLC, a company incorporated under the laws of England and Wales (the “Company”); and 

 

	(2)	The other persons and entities party hereto (each a “Purchaser,” and collectively the “Purchasers”). 

RECITAL: 
  

	(A)	The Company and the other persons and entities listed on the signature pages to this Deed are parties to a Securities Purchase Agreement dated as of October 12, 2009
(as amended and in effect from time to time, the “Purchase Agreement”). 

  

	(B)	The Purchasers have purchased from the Company the number of the Company’s Ordinary Shares (the “Ordinary Shares”), each Ordinary Share represented by
one American Depositary Share (each an “ADS”), and the number of warrants to purchase Ordinary Shares represented by ADSs (the “Warrants”) in each case as set forth opposite such Purchaser’s name on Exhibit A to the Purchase
Agreement. 

  

	(C)	The Purchasers and the Company wish to enter into this Deed to set forth their understanding and agreement with regard to the election and appointment of directors to
the Board of Directors of the Company (the “Board”). 

  

	(D)	In consideration of the mutual promises and covenants herein contained, and other consideration, the receipt and adequacy of which are hereby acknowledged, the parties
hereto agree as follows: 

  

	1.	DEFINITIONS 

  

	1.1	Capitalized terms used but not otherwise defined herein shall have the definitions ascribed to them in the Purchase Agreement. 

“Abingworth” means Abingworth LLP and its Affiliates, including, without limitation, Abingworth Bioventures V LP, Abingworth Bioventures V
Co-Invest Growth Equity Fund LP, and Abingworth Bioequities Master Fund Limited; 

 “Affiliate” means, with respect to any Person, any other Person controlling, controlled by or
under direct or indirect common control with such Person (for the purposes of this definition “control,” when used with respect to any specified Person, shall mean the power to direct the management and policies of such Person, directly or
indirectly, whether through ownership of voting securities, by contract or otherwise; and the terms “controlling” and “controlled” shall have meanings correlative to the foregoing). Without limiting the foregoing, in the case of
Abingworth, “Affiliate” shall include Abingworth’s managed accounts; 
 “Designated Director” shall mean in respect of
each Lead Investor and Abingworth, each person whom such Purchaser has designated for nomination or appointment to the Board pursuant to this Deed; 

“Investor” means each Purchaser together with and on behalf of its Affiliates from time to time holding or controlling Voting Securities;

 “Lead Investors” means the Lead Investors other than Longitude Venture Partners L.P. and its Affiliates; 

“Person” means any person, individual, corporation, limited liability company, partnership, trust or other nongovernmental entity or any
governmental agency, court, authority or other body (whether foreign, federal, state, local or otherwise); and 
 “Voting Securities”
means with respect to each Investor, the ADSs and Ordinary Shares (including ADSs and Ordinary Shares issued upon the exercise of Warrants) at the time held of record by such Investor or as to which it has voting control. 

 

	2.	NOMINATION AND ELECTION OF DIRECTORS 

  

	2.1	For so long as a Lead Investor, together with its Affiliates owning or controlling Voting Securities, beneficially owns the number of Ordinary Shares equal to at least
fifty percent (50%) of the number of Ordinary Shares it purchased at Closing, determined severally as to each Lead Investor, the Company will procure that the Board nominates for election to the Board in accordance with Article 110 of the
Company’s Articles of Association (as amended from time to time) each Designated Director specified by such Lead Director. 

  

	2.2	For so long as the Lead Investors, together with their Affiliates owning or controlling Voting Securities, beneficially own in the aggregate, at least twenty-five
percent (25%) of the then issued and outstanding Ordinary Shares of the Company, determined collectively as to the Lead Investors as a group, the Company will procure that the Board nominates for election to the Board in accordance with Article
110 of the Company’s Articles of Association (as amended from time to time) two Designated Directors (both of whom will be independent) specified by the Lead Investors. The identity of said two Designated Directors shall be determined in
accordance with procedures agreed among the Lead Investors. 

	2.3	For so long as Abingworth, together with its Affiliates owning or controlling Voting Securities, beneficially owns the number of Ordinary Shares equal to at least five
percent (5%) of the then issued and outstanding Ordinary Shares of the Company, the Company will procure that the Board nominates for election to the Board in accordance with Article 110 of the Company’s Articles of Association (as amended
from time to time) a Designated Director specified by Abingworth. 

  

	2.4	Each Investor, severally and not jointly, and solely with respect to its Voting Securities, agrees that: 

 

	 	(a)	at any meeting (whether general, extraordinary, annual or special and whether or not an adjourned or postponed meeting) of the holders of Ordinary Shares, however
called, or in connection with any written consent of the holders of Ordinary Shares, such Investor shall vote (or cause to be voted) all of its Voting Securities in favor of the election to the Board of each of the Designated Directors nominated by
the Lead Investors and Abingworth pursuant to this Section 2; and 

  

	 	(b)	such Investor shall not enter into any agreement or understanding with any Person the effect of which would be inconsistent with or would violate its obligations
hereunder. 

  

	3.	DESIGNATION OF DIRECTORS 

  

	3.1	On the Closing Date, the Designated Directors shall be as follows: 

  

	 	(i)	Carl L. Gordon shall be the Designated Director of the Orbimed Purchasers as shown on the signature page of this Deed; 

 

	 	(ii)	James I. Healy shall be the Designated Director of the Sofinnova Purchaser as shown on the signature page of this Deed; 

 

	 	(iii)	Manus Rogan shall be the Designated Director of the Fountain Purchaser as shown on the signature page of this Deed; and 

 

	 	(iv)	Joseph Anderson shall be the Designated Director of the Abingworth Purchasers as shown on the signature page of this Deed. 

 

	3.2	The parties acknowledge that although the Lead Investors have not yet specified Designated Directors in accordance with Section 2.2 of this Deed, the Lead
Investors reserve the right to designate such persons at any time after the date hereof. 

	3.3	From time to time during the term of this Deed, each Investor who is entitled to specify a Designated Director pursuant to this Deed may, in its sole discretion:

  

	 	(a)	notify the Company and the other Investors in writing of its intention to remove from the Board any of its Designated Directors; or 

 

	 	(b)	notify the Company and the other Investors in writing of its intention to designate a new Designated Director (whether to replace a prior Designated Director or to fill
a vacancy left by its prior Designated Director). 

  

	3.4	In the event of such an initiation of a removal or selection of a Designated Director under this Section 3, each other Investor shall vote its Voting Securities
and/or cause its Designated Directors, if any, to exercise his or her voting rights as a director in accordance with Article 111 of the Company’s Articles of Association (as amended from time to time) as may be necessary to cause: (a) the
removal from the Board of the Designated Director so specified for removal; and (b) the election to the Board of any such new Designated Director. 

  

	4.	NO LIABILITY FOR ELECTION OF DESIGNATED DIRECTOR 

None of the parties hereto and no officer, director, stockholder, partner, employee or agent of any party or its Affiliates makes any representation or
warranty as to the fitness or competence of any Designated Director by virtue of such party’s execution of this Deed, such party’s nomination or designation of a Designated Director hereunder, or such party’s vote for any Designated
Director pursuant to this Deed. 
  

	5.	PROXY 

 To secure the obligations of the
Investors to vote their Voting Securities in accordance with the provisions of this Deed, each Investor (each, a “Proxy Grantor”) hereby grants a power of attorney to each other Investor entitled hereunder to nominate or designate a
Designated Director (each, a “Proxy Grantee”) as its true and lawful proxy and attorney-in-fact, with full power of substitution, to vote all of such Proxy Grantor’s Voting Securities to give effect to the director nomination, removal
and designation rights of the Proxy Grantee hereunder, but only to the extent provided herein. Each Proxy Grantee may exercise the irrevocable proxy granted to it hereunder, in its sole discretion, at any time the Proxy Grantor fails to honor its
obligations under Sections 2 or 3 hereof in respect of persons nominated or designated by such Proxy Grantee. The proxies and powers granted pursuant to this Section 5 are 

 
coupled with an interest and are given to secure the performance of each of the obligations of the Investors hereunder. Such proxies and powers shall be irrevocable with respect to each Proxy
Grantee for so long as such Proxy Grantee is entitled hereunder to nominate or designate a Designated Director and shall survive the death, incompetency, disability, bankruptcy or dissolution of any Investor or any of its Affiliates. 

 

	6.	INDEMNIFICATION AGREEMENTS 

 For so long as any
Investor shall have the right to nominate or designate a Designated Director, the Company shall have entered into and will keep in effect an indemnification agreement with each such person who becomes a director, in form and substance mutually
satisfactory to the Company, Abingworth and the Lead Investors. 
  

	7.	COMPLIANCE WITH DEED AND ARTICLES 

  

	7.1	Each of the parties undertakes to each of the other parties that it will (so far as it is lawfully able) use the powers vested in it from time to time as director,
officer, employee and shareholder (as the case may be) to procure that the Company complies with its Articles of Association and this Deed. 

  

	7.2	Each of the parties will procure (so far as it is lawfully able) that the Articles of Association of the Company shall not be amended so as to frustrate the purposes of
the Deed. 

  

	7.3	Each of the parties undertakes to each of the other parties that it will comply with the obligations imposed on it by the Articles of Association.

  

	8.	TERMINATION 

 This Deed shall terminate only upon
the unanimous written consent of the Investors who at the time have the right to nominate or designate members of the Board as provided herein. 
  

	9.	ADDITIONAL SECURITIES 

 For the avoidance of
doubt, in the event that, subsequent to the date of this Deed, any voting shares or other voting securities are issued on, or in exchange for, any of ADSs or Ordinary Shares by reason of any stock dividend, stock split, consolidation of shares,
reclassification or consolidation involving the Company, the additional Ordinary Shares, ADSs and other such shares or securities so issued shall be deemed to be Voting Securities for purposes of this Deed. 

	10.	MISCELLANEOUS 

  

	10.1	Successors and Assigns. The provisions of this Deed shall inure to the benefit of, and be binding upon, the successors, heirs, executors, administrators and permitted
assigns of the parties hereto, provided that this Agreement may not be assigned by any party hereto except to its Affiliates owning or controlling Voting Securities and this Deed shall not be binding on Persons to whom a Purchaser transfers Voting
Securities unless such transferee is an Affiliate of the transferring Purchaser. Each Purchaser (i) agrees to cause its Affiliates from time to time holding or controlling Voting Securities to comply with the provisions hereof binding on such
Purchaser and its Affiliates and (ii) shall be liable to the other Investors for any breach of this Deed by its Affiliates. 

  

	10.2	Governing Law. This Deed and any non contractual obligations arising out of it shall be governed by the laws of England and Wales, and the parties submit to the
exclusive jurisdiction of the English courts for the purpose of hearing and determining any dispute arising out of or in connection with this Deed (including a dispute regarding the existence, validity or termination of this Deed or any contractual
or non-contractual obligation arising out of or in connection with this Deed) and for the purpose of enforcement of any judgment against their respective assets. 

 

	10.3	Further Assurances. Each party hereto agrees to execute and deliver, by the proper exercise of its corporate, limited liability company, partnership or other powers,
all such other and additional instruments and documents and do all such other acts and things as may be necessary to more fully effectuate this Deed. 

  

	10.4	Entire Agreement. This Deed and the Purchase Agreement (and the exhibits thereto) constitute the full and entire understanding and agreement among the parties with
regard to the subject hereof. 

  

	10.5	Specific Performance. It is agreed and understood that monetary damages would not adequately compensate an injured party for the breach of this Deed by any party, that
this Deed shall be specifically enforceable, and that any breach or threatened breach of this Deed shall be the proper subject of a temporary or permanent injunction or restraining order. Further, each party hereto waives any claim or defense that
there is an adequate remedy at law for such breach or threatened breach. 

	10.6	Amendment; Waiver. Neither this Deed nor any term hereof may be amended or waived other than by the unanimous consent of the Investors who at the time have the right to
nominate or designate Members of the Board as provided herein; provided, however, that (i) any Investor may unilaterally waive its rights (but not its obligations) hereunder but only by a written instrument signed by such Investor, and any such
waiver shall be binding only upon such Investor and (ii) no such amendment or waiver shall increase the obligations of the Company or any Investor who does not have the right to nominate or appoint a Designated Director as provided herein
without the Company’s such Investor’s prior written consent, as the case may be. 

  

	10.7	Attorney’s Fees. In the event that any suit or action is instituted to enforce any provision in this Deed, the prevailing party in such dispute shall be entitled
to recover from the losing party such reasonable fees and expenses of attorneys and accountants, which shall include, without limitation, all fees, costs and expenses of appeals. 

 

	10.8	Severability. If any provision of this Deed becomes or is declared by a court of competent jurisdiction to be illegal, unenforceable or void, portions of such
provision, or such provision in its entirety, to the extent necessary, shall be severed from this Deed, and such court will replace such illegal, void or unenforceable provision of this Deed with a valid and enforceable provision that will achieve,
to the extent possible, the same economic, business and other purposes of the illegal, void or unenforceable provision. The balance of this Deed shall be enforceable in accordance with its terms. 

 

	10.9	Counterparts. This Deed may be executed in one or more counterparts, each of which will be deemed an original, but all of which together will constitute one and the
same agreement. Facsimile copies of signed signature pages will be deemed binding originals. 

  

	10.10 	Delays or Omissions. It is agreed that no delay or omission to exercise any right, power or remedy accruing to any party, upon any breach, default or noncompliance by
another party under this Deed shall impair any such right, power or remedy, nor shall it be construed to be a waiver of any such breach, default or noncompliance, or any acquiescence therein, or of or in any similar breach, default or noncompliance
thereafter occurring. It is further agreed that any waiver, permit, consent or approval of any kind or character on any party’s part of any breach, default or noncompliance under this Deed or any waiver on such party’s part of any
provisions or conditions of the Deed must be in writing and shall be effective only to the extent specifically set forth in such writing. All remedies, either under this Deed by law, or otherwise afforded to any party, shall be cumulative and not
alternative. 

	10.11 	Independent Nature of Investors’ Obligations and Rights. Nothing contained in this Deed or in the Purchase Agreement, and no action taken by any party hereto
pursuant thereto, shall be deemed to constitute the Investors as a partnership, an association, a joint venture or any other kind of entity, or create a presumption that the Investors are in any way acting in concert or as a group with respect to
such obligations or the transactions contemplated by this Deed and the Purchase Agreement. Each Investor shall be entitled to independently protect and enforce its rights, including without limitation the rights arising out of this Deed or out of
the Purchase Agreement, and it shall not be necessary for any other Investor to be joined as an additional party in any proceeding for such purpose. Each Investor has been represented by its own separate legal counsel in its review and negotiation
of this Deed and the Purchase Agreement. 

 This Deed has been entered into and delivered as a deed on the date stated at the
beginning of this Deed. 
 [SIGNATURE PAGE FOLLOWS] 

IN WITNESS WHEREOF, the parties have executed this Management Rights Deed of Agreement as a deed as of the date first above written. 

 

			
	 The Company

Executed as a deed by
 AMARIN CORPORATION PLC

		
	By:	 	/s/ William T. Mason
	Name: William T. Mason
	Title: Director
	
	 The Orbimed Purchasers

Executed as a deed by
 CADUCEUS PRIVATE
INVESTMENTS III, LP

		
	By:	 	OrbiMed Capital GP III LLC
	Its:	 	General Partner
		
	By:	 	/s/ Carl L. Gordon
	Name: Carl L. Gordon
	Title: General Partner

			
	 Executed as a deed by

ORBIMED ASSOCIATES III, LP

		
	By:	 	OrbiMed Advisors LLC
	Its:	 	General Partner
		
	By:	 	/s/ Carl L. Gordon
	Name: Carl L. Gordon
	Title: Partner
	
	 The Sofinnovia Purchaser

Executed as a deed by
 SOFINNOVA VENTURE PARTNERS
VII, L.P.

		
	By:	 	Sofinnova Management VII, L.L.C.
	Its:	 	General Partner
		
	By:	 	/s/ James I. Healy
	Name: James I. Healy
	Title: Managing General Partner
	
	 The Fountain Purchaser

Executed as a deed by
 FOUNTAIN HEALTHCARE
PARTNERS FUND 1, L.P.

		
	By:	 	Fountain Healthcare Partners Ltd.
	Its:	 	General Partner
		
	By:	 	/s/ Manus Rogan
	Name: Manus Rogan
	Title: Managing Partner
	
	 The Abingworth Purchasers

Executed as a deed by
 ABINGWORTH BIOVENTURES V
L.P

		
	By:	 	Abingworth LLP
	Its:	 	Manager
		
	By:	 	/s/ Joseph Anderson
	Name: Joseph Anderson
	Title: Partner
		
	By:	 	/s/ Timothy Haines
	Name: Timothy Haines
	Title: Partner

			
	 Executed as a deed by

ABINGWORTH BIOVENTURES V
 CO-INVEST GROWTH EQUITY
FUND LP

		
	By:	 	Abingworth LLP
	Its:	 	Manager
		
	By:	 	/s/ Joseph Anderson
	Name: Joseph Anderson
	Title: Partner
		
	By:	 	/s/ Timothy Haines
	Name: Timothy Haines
	Title: Partner
	
	 Executed as a deed by

ABINGWORTH BIOEQUITIES
 MASTER FUND
LIMITED

		
	By:	 	/s/ Joseph Anderson
	 Name: Joseph Anderson

Title: Director

	
	 The Other Purchasers

Executed as a deed by
 STICHTING DEPOSITARY APG

 DEVELOPED MARKETS EQUITY POOL

		
	By:	 	/s/ R. Van Der Zeeuw
	Name: R. Van Der Zeeuw
	Title: Authorized Signatory
		
	By:	 	/s/ P.M.L. Frentrop
	Name: P.M.L. Frentrop
	Title: Authorized Signatory
	
	 Executed as a deed by

BIOMEDICAL OFFSHORE VALUE FUND, LTD.

		
	By:	 	Great Point Partners, LLC, its Investment Manager
		
	By:	 	 
	 Name: Jeffrey R. Jay

Title: Senior Managing Member

			
	 Executed as a deed by

BIOMEDICAL VALUE FUND, L.P.

		
	By:	 	Great Point Partners, LLC, its General Partner
		
	By:	 	 
	Name: Jeffrey R. Jay
	Title: Senior Managing Member
	
	 Executed as a deed by

VISIUM BALANCED MASTER FUND, LTD.

		
	By:	 	 
	Name: Mark Gottlieb
	Title: Signatory
	
	 Executed as a deed by

OPUS POINT HEALTHCARE INNOVATIONS FUND, L.P.

		
	By:	 	 
	Name: Michael S. Weiss
	Title: Manager of the Investment Manager
	
	 Executed as a deed by

OPUS POINT HEALTHCARE VALUE FUND, L.P.

		
	By:	 	 
	Name: Michael S. Weiss
	Title: Manager of the Investment Manager
	
	 Executed as a deed by

OPUS POINT HEALTHCARE (LOW NET) FUND, L.P.

		
	By:	 	 
	Name: Michael S. Weiss
	Title: Manager of the Investment Manager
	
	 Executed as a deed by

OPUS POINT CAPITAL PRESERVATION FUND, L.P.

		
	By:	 	 
	Name: Michael S. Weiss
	Title: Manager of the Investment Manager

			
	 Executed as a deed by

CAPITAL VENTURES INTERNATIONAL

		
	By:	 	 
	 Name: Martin Kobinger

Title: Investment Manager

	
	 Executed as a deed by

CUMMINGS BAY CAPITAL

		
	By:	 	 
	 Name: Michael Gregory

Title: Authorised Person

	
	 Executed as a deed by

GENEVE CORP.

		
	By:	 	 
	 Name: Michael Gregory

Title: Authorised Person

	
	 Executed as a deed by

BIOHEDGE HOLDINGS LIMITED

		
	By:	 	 
	 Name: Steven Salmon

Title: President, Rosalind Advisors, Inc.

	
	 Executed as a deed by

ROSALIND CAPITAL PARTNERS, L.P.

		
	By:	 	 
	 Name: Steven Salmon

Title: President, Rosalind Advisors, Inc.

	
	 Executed as a deed by

BOXER CAPITAL LLC

		
	By:	 	/s/ Chris Fuglesang
	 Name: Chris Fuglesang

Title: Member, Counsel

	
	 Executed as a deed by

RCG PB LTD.

		
	By:	 	 
	 Name: Jeffrey C. Smith

Title: Authorized Signatory

			
	 Executed as a deed by

RAMIUS ENTERPRISE MASTER FUND LTD.

		
	By:	 	 
	 Name: Jeffrey C. Smith

Title: Authorized Signatory

	
	 Executed as a deed by

RA CAPITAL HEALTHCARE FUND, L.P.

		
	By:	 	 
	 Name: Peter Kolchinsky

Title: Manager

	
	 Executed as a deed by

BLACKWELL PARTNERS, LLC

		
	By:	 	 
	 Name: Peter Kolchinsky

Title: Manager

	
	 Executed as a deed by

SUNNINGHILL LIMITED

		
	By:	 	 
	 Name:
 Title:
Director

		
	By:	 	 
	 Name:
 Title:
Director

	
	 Executed as a deed by

MIDSUMMER VENTURES, LP

		
	By:	 	 
	 Name: Michael Amsalem

Title: President of General Partner, Midsummer Advisors

	
	 Executed as a deed by

MIDSUMMER INVESTMENT, LIMITED

		
	By:	 	 
	 Name: Michael Amsalem

Title: Director

			
	
	/s/ David Brabazon
	David Brabazon
	
	 
	David Hurley
	
	/s/ Thomas G. Lynch
	Thomas G. Lynch
	
	/s/ Dr. Simon Kukes
	Dr. Simon Kukes
	
	 
	Eunan Maguire
	
	/s/ Anthony Russell Roberts
	Anthony Russell Roberts
	
	 Executed as a deed by

LONGITUDE VENTURE PARTNERS, L.P.

	
	 By: Longitude Capital Partners, LLC

Its: General Partner

		
	By:	 	/s/ Patrick Enright
	 Name: Patrick Enright

Title: Managing Director

	
	 Executed as a deed by

LONGITUDE CAPITAL ASSOCIATES, L.P.

	
	 By: Longitude Capital Partners, LLC

Its: General Partner

		
	By:	 	/s/ Patrick Enright
	 Name: Patrick Enright

Title: Managing Director

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00175-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00175-of-00352.parquet"}]]